Cancer drug prices to fall by up to 70 pc under 30 pc trade margin cap from November 9

Maximum retail prices for 137 critical non-scheduled anti-cancer drugs have been reduced by up to 70 percent. This change follows a new government rule capping the trade margin at 30 percent.